Detalhe da pesquisa
1.
T cell immunotherapies engage neutrophils to eliminate tumor antigen escape variants.
Cell
; 186(7): 1432-1447.e17, 2023 03 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-37001503
2.
B cells and tertiary lymphoid structures promote immunotherapy response.
Nature
; 577(7791): 549-555, 2020 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-31942075
3.
Neoadjuvant plus adjuvant dabrafenib and trametinib versus standard of care in patients with high-risk, surgically resectable melanoma: a single-centre, open-label, randomised, phase 2 trial.
Lancet Oncol
; 19(2): 181-193, 2018 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-29361468
4.
Nurse and patient characteristics predict communication about complementary and alternative medicine.
Cancer
; 122(10): 1552-9, 2016 05 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-26991683
5.
Cell culture model that mimics drusen formation and triggers complement activation associated with age-related macular degeneration.
Proc Natl Acad Sci U S A
; 108(45): 18277-82, 2011 Nov 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-21969589
6.
Randomized Placebo-Controlled, Biomarker-Stratified Phase Ib Microbiome Modulation in Melanoma: Impact of Antibiotic Preconditioning on Microbiome and Immunity.
Cancer Discov
; : OF1-OF15, 2024 Apr 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-38588588
7.
Prior anti-CTLA-4 therapy impacts molecular characteristics associated with anti-PD-1 response in advanced melanoma.
Cancer Cell
; 41(4): 791-806.e4, 2023 04 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-37037616
8.
Obesity Is Associated with Altered Tumor Metabolism in Metastatic Melanoma.
Clin Cancer Res
; 29(1): 154-164, 2023 01 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-36166093
9.
Hallmarks of Resistance to Immune-Checkpoint Inhibitors.
Cancer Immunol Res
; 10(4): 372-383, 2022 04 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-35362046
10.
Dietary fiber and probiotics influence the gut microbiome and melanoma immunotherapy response.
Science
; 374(6575): 1632-1640, 2021 Dec 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-34941392
11.
Gut microbiota signatures are associated with toxicity to combined CTLA-4 and PD-1 blockade.
Nat Med
; 27(8): 1432-1441, 2021 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-34239137
12.
Spatially resolved analyses link genomic and immune diversity and reveal unfavorable neutrophil activation in melanoma.
Nat Commun
; 11(1): 1839, 2020 04 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-32296058
13.
It Is a Capital Mistake to Theorize Who to Treat with Checkpoint Inhibitors before One Has Data.
Trends Cancer
; 5(2): 79-82, 2019 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-30755306
14.
The Influence of the Gut Microbiome on Cancer, Immunity, and Cancer Immunotherapy.
Cancer Cell
; 33(4): 570-580, 2018 04 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-29634945
15.
Author Correction: Neoadjuvant immune checkpoint blockade in high-risk resectable melanoma.
Nat Med
; 24(12): 1941, 2018 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-30361510
16.
Publisher Correction: Neoadjuvant immune checkpoint blockade in high-risk resectable melanoma.
Nat Med
; 24(12): 1942, 2018 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-30361511
17.
Neoadjuvant immune checkpoint blockade in high-risk resectable melanoma.
Nat Med
; 24(11): 1649-1654, 2018 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-30297909
18.
Parallel profiling of immune infiltrate subsets in uveal melanoma versus cutaneous melanoma unveils similarities and differences: A pilot study.
Oncoimmunology
; 6(6): e1321187, 2017.
Artigo
em Inglês
| MEDLINE | ID: mdl-28680759
19.
Integrated molecular analysis of tumor biopsies on sequential CTLA-4 and PD-1 blockade reveals markers of response and resistance.
Sci Transl Med
; 9(379)2017 03 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-28251903
20.
Genomic and immune heterogeneity are associated with differential responses to therapy in melanoma.
NPJ Genom Med
; 22017.
Artigo
em Inglês
| MEDLINE | ID: mdl-28819565